Whitehawk Therapeutics, Inc.
WHWK
$3.92
$0.123.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.24% | -41.45% | -260.80% | 499.23% | -12.32% |
| Total Depreciation and Amortization | -97.87% | -89.36% | -67.35% | 14.00% | 6.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.93% | -7.04% | 20.34% | -2,664.97% | -36.20% |
| Change in Net Operating Assets | 212.91% | 103.34% | -222.67% | 115.42% | -62.90% |
| Cash from Operations | -14.49% | 1.97% | -478.32% | 39.63% | -56.09% |
| Capital Expenditure | 100.00% | 100.00% | 99.82% | 25.44% | 77.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.48% | -1,836.34% | -851.32% | 30.10% | 198.30% |
| Cash from Investing | 28.27% | -1,901.91% | -707.22% | 994.25% | 259.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.92% | -- | -69.15% | -- | -54.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -12,457.14% | -48,120.00% | 102.94% |
| Cash from Financing | -52.83% | -- | -1,077.01% | 952,110.00% | -33.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.56% | -909.29% | -553.69% | 2,283.08% | 68.44% |